{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:35:43Z","timestamp":1788816943453,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019418","name":"National Institute for Health Research Maudsley Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ynirp.2026.100337","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:39:05Z","timestamp":1774985945000},"page":"100337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular neuroimaging of Parkinson's disease: association of motor and non-motor symptoms with synaptic density, dopaminergic and serotonergic systems"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6102-7272","authenticated-orcid":false,"given":"Julia J.","family":"Schubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Batzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Zinzalias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazneen","family":"Barwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair D.","family":"Reith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3474-5735","authenticated-orcid":false,"given":"Christine A.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve C.R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ynirp.2026.100337_bib1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/mds.25647","article-title":"Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations","volume":"28","author":"Alcalay","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100337_bib2","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/mds.28617","article-title":"Reduced synaptic density in patients with lewy body dementia: an [11C]UCB-J PET imaging study","volume":"36","author":"Andersen","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100337_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.729755","article-title":"Cognitive decline in parkinson's disease: a subgroup of extreme decliners revealed by a data-driven analysis of longitudinal progression","volume":"12","author":"Andersson","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.ynirp.2026.100337_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A fast diffeomorphic image registration algorithm","volume":"38","author":"Ashburner","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.ynirp.2026.100337_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00702-012-0956-y","article-title":"In vivo neurochemical imaging of olfactory dysfunction in parkinson's disease","volume":"120","author":"Bohnen","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ynirp.2026.100337_bib6","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/mds.22212","article-title":"Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB","volume":"23","author":"Boileau","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100337_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ynirp.2026.100337_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jnnp.73.6.629","article-title":"The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease","volume":"73","author":"Chaudhuri","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ynirp.2026.100337_bib9","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/mds.28216","article-title":"Loss of presynaptic terminal integrity in the substantia nigra in early parkinson's disease","volume":"35","author":"Delva","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100337_bib10","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/mds.29148","article-title":"Longitudinal positron emission tomography imaging of presynaptic terminals in early parkinson's disease","volume":"37","author":"Delva","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100337_bib11","doi-asserted-by":"crossref","DOI":"10.1088\/0031-9155\/57\/21\/R119","article-title":"A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology","volume":"57","author":"Erlandsson","year":"2012","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.ynirp.2026.100337_bib12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/mds.27316","article-title":"Nigrostriatal dopamine transporter availability in early Parkinson's disease","volume":"33","author":"Fazio","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100337_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2217\/nmt-2016-0005","article-title":"Nondopaminergic treatments for Parkinson's disease: current and future prospects","volume":"6","author":"Freitas","year":"2016","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.ynirp.2026.100337_bib14","series-title":"Statistical Parametric Mapping: the Analysis if Functional Brain Images","author":"Friston","year":"2006"},{"key":"10.1016\/j.ynirp.2026.100337_bib15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.nicl.2018.05.022","article-title":"Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB\/PET","volume":"19","author":"Fu","year":"2018","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.ynirp.2026.100337_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gigascience\/giae049","article-title":"A computational anatomy toolbox for the analysis of structural MRI data","volume":"13","author":"Gaser","year":"2024","journal-title":"GigaScience"},{"key":"10.1016\/j.ynirp.2026.100337_bib17","first-page":"1928","article-title":"Molecular imaging and kinetic analysis toolbox (MIAKAT) - a quantitative software package for the analysis of PET neuroimaging data","volume":"57","author":"Gunn","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ynirp.2026.100337_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1468-1331.2007.01727.x","article-title":"Brain serotonin transporter binding in non-depressed patients with Parkinson's disease","volume":"14","author":"Guttman","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ynirp.2026.100337_bib19","first-page":"1","article-title":"Synaptic loss and its association with symptom severity in Parkinson's disease","volume":"10","author":"Holmes","year":"2024","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.ynirp.2026.100337_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/braincomms\/fcae345","article-title":"Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [18F]FE-PE2I PET: independent validation with new insights","volume":"6","author":"Honhar","year":"2024","journal-title":"Brain Commun"},{"key":"10.1016\/j.ynirp.2026.100337_bib21","first-page":"1","article-title":"Links between COVID-19 and Parkinson's disease\/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms","volume":"12","author":"Huang","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ynirp.2026.100337_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-018-0450-0","article-title":"Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT\u2014A clinical comparison","volume":"8","author":"Jakobson Mo","year":"2018","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ynirp.2026.100337_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-023-00974-7","article-title":"[18F]FE-PE2I DAT correlates with Parkinson's disease duration, stage, and rigidity\/bradykinesia scores: a PET radioligand validation study","volume":"13","author":"Kerstens","year":"2023","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ynirp.2026.100337_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117157","article-title":"Longitudinal evolution of non-motor symptoms according to age at onset in early Parkinson \u2019 s disease","volume":"418","author":"Kim","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ynirp.2026.100337_bib25","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100337_bib26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1212\/WNL.0000000000001909","article-title":"Putaminal serotonergic innervation: monitoring dyskinesia risk in Parkinson disease","volume":"85","author":"Lee","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ynirp.2026.100337_bib27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3233\/JAD-220003","article-title":"Stability of Montreal cognitive assessment in individuals with mild cognitive impairment: potential influence of practice effect","volume":"87","author":"Lei","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ynirp.2026.100337_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nn.4479","article-title":"REM sleep selectively prunes and maintains new synapses in development and learning","volume":"20","author":"Li","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ynirp.2026.100337_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2019.00057","article-title":"The combination of DAT-SPECT, structural and diffusion MRI predicts clinical progression in parkinson's disease","volume":"11","author":"Lorio","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ynirp.2026.100337_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2967\/jnumed.119.228080","article-title":"Characterization of 3 PET tracers for quantification of mitochondrial and synaptic function in healthy human brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-J","volume":"61","author":"Mansur","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ynirp.2026.100337_bib31","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/mds.26614","article-title":"Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease","volume":"31","author":"Marras","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100337_bib32","first-page":"1","article-title":"PET imaging of synaptic density in Parkinsonian disorders","volume":"102","author":"Martin","year":"2023","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ynirp.2026.100337_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ana.25682","article-title":"Synaptic changes in parkinson disease assessed with in vivo imaging","volume":"87","author":"Matuskey","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ynirp.2026.100337_bib34","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/alz.12582","article-title":"Synaptic density and cognitive performance in Alzheimer's disease: a PET imaging study with [11C]UCB-J","volume":"18","author":"Mecca","year":"2022","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"10.1016\/j.ynirp.2026.100337_bib35","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1212\/01.wnl.0000335973.66333.58","article-title":"Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study","volume":"71","author":"Nandhagopal","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ynirp.2026.100337_bib36","article-title":"Longitudinal changes in grey matter and cognitive performance over four years of healthy aging","volume":"2","author":"Neufeld","year":"2022","journal-title":"Neuroimage: Reports"},{"key":"10.1016\/j.ynirp.2026.100337_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0271678X18770107","article-title":"Cerebral serotonin transporter measurements with [ 11 C]DASB: a review on acquisition and preprocessing across 21 PET centres","volume":"39","author":"N\u00f8rgaard","year":"2019","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ynirp.2026.100337_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.24859","article-title":"Serotonin transporter in Parkinson's disease: a meta-analysis of positron emission tomography studies","volume":"81","author":"Pagano","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ynirp.2026.100337_bib39","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/brain\/awq268","article-title":"Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction","volume":"133","author":"Pavese","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ynirp.2026.100337_bib40","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.20731","article-title":"Lrrk2 and lewy body disease","volume":"59","author":"Ross","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ynirp.2026.100337_bib41","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1177\/0271678X19879230","article-title":"Assessment of a white matter reference region for 11C-UCB-J PET quantification","volume":"40","author":"Rossano","year":"2020","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ynirp.2026.100337_bib42","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100337_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/mds.27361","article-title":"Longitudinal change of clinical and biological measures in early parkinson's disease: parkinson's progression markers initiative cohort","volume":"33","author":"Simuni","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100337_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2018.00088","article-title":"Relationships between serotonin transporter binding in the raphe nuclei, basal ganglia, and hippocampus with clinical symptoms in cervical dystonia: a [11C]DASB positron emission tomography study","volume":"9","author":"Smit","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ynirp.2026.100337_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/tnsci-2016-0007","article-title":"The serotonergic system and cognitive function","volume":"7","author":"\u0160trac","year":"2016","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.ynirp.2026.100337_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00415-010-5666-5","article-title":"Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter","volume":"258","author":"Strecker","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.ynirp.2026.100337_bib47","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","article-title":"Imaging dopamine receptors in humans with [ 11 C ] - ( + ) -PHNO : dissection of D3 signal and anatomy","volume":"54","author":"Tziortzi","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.ynirp.2026.100337_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.parkreldis.2011.04.002","article-title":"Estimation of further disease progression of Parkinson's disease by dopamin transporter scan vs clinical rating","volume":"17","author":"Vogt","year":"2011","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.ynirp.2026.100337_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1353-8020(08)70007-5","article-title":"Clinical genetics of Parkinson's disease and related disorders","volume":"13","author":"Wider","year":"2007","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.ynirp.2026.100337_bib50","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1474-4422(17)30056-X","article-title":"Serotonin transporter binding and motor onset of Parkinson's disease in asymptomatic LRRK2 mutation carriers: a cross-sectional study","volume":"16","author":"Wile","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ynirp.2026.100337_bib51","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/mds.28064","article-title":"Mitochondrial complex 1, sigma 1, and synaptic vesicle 2A in early drug-naive parkinson's disease","volume":"35","author":"Wilson","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ynirp.2026.100337_bib52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12915-024-02039-0","article-title":"Molecular mechanisms underlying the neural correlates of working memory","volume":"22","author":"Xu","year":"2024","journal-title":"BMC Biol."}],"container-title":["NeuroImage: Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666956026000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666956026000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:38:42Z","timestamp":1785267522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666956026000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666956026000206"],"URL":"https:\/\/doi.org\/10.1016\/j.ynirp.2026.100337","relation":{},"ISSN":["2666-9560"],"issn-type":[{"value":"2666-9560","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular neuroimaging of Parkinson's disease: association of motor and non-motor symptoms with synaptic density, dopaminergic and serotonergic systems","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ynirp.2026.100337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100337"}}